Are you or a loved one interested in receiving stem cell treatment? For free information, please fill out our
treatment form or email me don@repairstemcells.org and just put TREATMENT in the subject box and the MEDICAL CONDITION in the message.
ANOTHER ADULT STEM CELL TREATMENT SUCCESS STORY CAME OUT OF CHINA TODAY. A COUPLE FROM GEORGIA CAME ALL THE WAY TO CHINA TO RECEIVE STEM CELL TREATMENT FOR THEIR 7 MONTH OLD DAUGHTER WHO IS SUFFERING FROM OPTIC NERVE HYPOPLASIA (ONH). FOR ALL OF YOU LAYMEN (INCLUDING MYSELF WHO HAD TO LOOK IT UP ON GOOGLE), IT MEANS THE 7 MONTH YEAR OLD WAS BLIND! IS SHE BLIND NOW AFTER THE STEM CELL THERAPY? READ ON AND FIND OUT!
Treatment Seems to Yield Positive ResultsAfter three sessions, Teague and Williams say the therapy is already working.
The doctors have told Laylah's parents that the baby now sees light through one eye, while the other eye is dilating almost to the point where she can see light.
So far, 10 patients suffering from ONH have received the same stem-cell treatment in China, and doctors there claim that the vision of all 10 improved after the therapy.
At age 5, Rylea Barlett also received the stem-cell treatment. She, too, had been blind before.
Dr. Shalesh Kaushal, an eye specialist at the University of Florida, examined Bartlett, who is now 6, after she returned to the U.S.
"This child had essentially no light perception, and upon returning she's had a gradual improvement so much so that at our exam it appeared that she had formed vision," he says. "That is to say that she could at least recognize large letters."
Kaushal concluded that the stem-cell therapy was the only clinical explanation for her improvement. Some infants with ONH gain more vision spontaneously over the first few years of life, but Barlett was already too old for that.
Kaushal is now evaluating other patients before and after the stem-cell treatment. But he is not recommending that patients go to China; he says much more research needs to be done.
"It's clearly a provocative result. ¦ If this is a real, reproducible observation or effect in other patients, one may consider it as a fundamental breakthrough," says Kaushal.
CLICK HERE TO READ THE WHOLE ARTICLE